Reactor malfunction results in employee death at India-based CRO
One worker has died at GVK Bio’s Hyderabad site after a reactor malfunctioned, though the root cause remains unknown, according to the CRO.
Archives for July 11, 2019
DSP Clinical unveils new co-monitoring service
DSP Clinical provides flexible monitoring support to sponsors and CROs through a new co-monitoring service that takes advantage of fluctuations in employee demand.
Elligo expands research network with oncology center partnership
Elligo expands its Research Ready network and adds its first oncology practice through a partnership with Austin Cancer Center, which is currently enrolling patients for breast cancer studies.
As ‘transformational’ as the internet: Alten adds blockchain initiative
Alten Calsoft Labs launches its first initiative for blockchain through its scalable clinical trial platform BioPharma Ledger to address life sciences processes using BlockApps middleware.
‘Increasing visibility’: Repositive relaunches Cancer Models platform with accessible directory
Repositive ‘increases visibility’ while ‘maintaining confidentiality’ as it makes its directory of preclinical cancer models publicly browsable as part of the relaunch of its Cancer Models Platform.
Akorn’s warning letter reveals 'inadequate' investigations into manufacturing issues
The US FDA published another warning letter sent to Akorn, which details cases of improper investigation into faulty batches, failure to exercise controls over data, and ‘poor aseptic behaviour’.
Tufts, Saama set out to ‘optimize’ clinical development via research tie-up
Saama and Tufts are teaming up to examine how sponsors and CROs are using automation and information technology in an aim to identify new solutions and optimize drug development.
Charles River to open flexible vivarium space in San Francisco
The new lab will provide customers with 'low cost, turnkey' vivarium space in addition to various in vivo support services.
Erytech-SQZ collaboration to ‘realize immune-modulating potential’
Erytech entered an agreement with SQZ to advance RBC-based therapeutics for immune modulation using the latter’s platform.
Gilead and Lyndra co-develop long-acting HIV therapies
Following Gilead’s funding of Lyndra’s technology, the latter company offers exclusive rights to its therapeutics platform for long-acting HIV therapies formulations.
‘Removing the need for other partners’: Onyx invests in commercial API license
Onyx invests in a commercial API license and expands its UK facility to bolster its manufacturing capabilities for niche, small-scale production.